drugset
drugset / Trial / NCT01337531

Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)

NCT01337531 ↗

Phase 2 Unknown 200 enrolled Genesis Center for Fertility & Human Pre-Implantation Genetics
RandomizedSingle-groupDouble-blindTreatment

Summary

Control ovarian stimulation responses, pregnancy and miscarriage rates are indifferent when either recombinant or highly purified follicle stimulating hormone (FSH) is used.

Timeline

Start
2011-05
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown — Other
Comparator Gonal-f Protein / enzyme biologic — Other

Indications

polycystic ovary syndrome